For reading questions, the sources are open.
We give no medical advice and don’t run a contact inbox or a message form. You can check a claim through the linked papers. The notes below help you find the right place to look.
Corrections
If a sentence here seems wrong, the source beside it is the most useful place to look. Does the paper support that exact sentence? Sometimes a disagreement is about the result. Sometimes it’s about how far the wording stretches beyond the result.
Keep the page, the sentence and the linked finding together as you read. That makes the point of disagreement easier to see. A broad statement such as “KPV works” leaves too much open: works for what, in whom, and measured how?
The references page gathers every source we cite. You can use it to find a paper again or compare its title with the claim you’re checking. No account or personal details are needed to follow those links. There’s no submission step on this page.
Care
A question about your own symptoms or treatment needs someone who can assess you. This publication can explain what a trial found. It can’t check a reaction, choose a medicine or tell you how a finding applies to your health.
For a clinical conversation, the exact product and the question about it are useful things to keep clear. A study of one preparation doesn’t automatically answer a question about another. We explain that distinction here, while leaving individual decisions with a qualified healthcare professional.
This page also has no way to receive or monitor an urgent health concern. Urgent or emergency services provide a different kind of help from a reading publication. Nothing entered or read here connects you to a clinician, and these pages offer no emergency response.
Reading
If you’re unsure which page to read, choose the question closest to yours. KPV looks at inflammation and delivery. BPC-157 looks at repair claims and small human reports. NAD+ separates the molecule from the building blocks tested in studies.
For weight-loss findings, retatrutide and tirzepatide have separate accounts. That gives each trial result and approval status room to be explained. A shared search category doesn’t mean the compounds have the same evidence or the same route to human use.
If your question joins two names, the questions page looks at combinations. It checks whether the cited studies tested the substances together. That’s a useful reading check to make before treating two separate findings as evidence about a pair.